Death Receptor 5 Displayed on Extracellular Vesicles Decreases TRAIL Sensitivity of Colon Cancer Cells

Tumor necrosis factor–related apoptosis inducing ligand (TRAIL) is considered to be a promising antitumor drug because of its selective proapoptotic properties on tumor cells. However, the clinical application of TRAIL is until now limited because of the resistance of several cancer cells, which can...

Descripción completa

Detalles Bibliográficos
Autores principales: Setroikromo, Rita, Zhang, Baojie, Reis, Carlos R., Mistry, Rima H., Quax, Wim J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248226/
https://www.ncbi.nlm.nih.gov/pubmed/32509779
http://dx.doi.org/10.3389/fcell.2020.00318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248226/
https://www.ncbi.nlm.nih.gov/pubmed/32509779
http://dx.doi.org/10.3389/fcell.2020.00318

Ejemplares similares